ObjectiveTo investigate the feasibility of pre- and post-encounter patient-reported outcome (PRO) measure collection within an outpatient integrative health and medicine (IHM) clinic and to characteri
These data were collected as part of a larger longitudinal study aiming to examine treatment effects of highly-emetogenic chemotherapies among cancer patients at two timepoints: pre-chemotherapy (base
Introduction: Regulatory agencies encourage the incorporation of the patient voices throughout clinical drug development. Patient-Reported Outcomes (PROs) offer one way of doing this and their use has
